WO2004032734A1 - Verfahren und vorrichtung zur nichtinvasiven untersuchung von stoffwechelprozessen - Google Patents
Verfahren und vorrichtung zur nichtinvasiven untersuchung von stoffwechelprozessen Download PDFInfo
- Publication number
- WO2004032734A1 WO2004032734A1 PCT/DE2003/003278 DE0303278W WO2004032734A1 WO 2004032734 A1 WO2004032734 A1 WO 2004032734A1 DE 0303278 W DE0303278 W DE 0303278W WO 2004032734 A1 WO2004032734 A1 WO 2004032734A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fluorescence
- metabolism
- light
- control
- processes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
Definitions
- the invention relates to a method and an arrangement for the force-invasive examination of control and regulatory processes in human and animal metabolism in order to be able to draw conclusions about specific diseases from the changes in individual metabolic parameters.
- This procedure is used in preventive examinations for early detection of cancer, inflammatory diseases and the determination of the need for antioxidants, the therapy control of the individual clinical pictures as well as the routine examination in professional groups with particular physical and psychological stress.
- Fluorescence spectrometric studies have been known for some years as highly accurate and very specific methods in basic biological research on transport processes through biological membranes and biomedical studies as diagnostic tools. Currently in a steady, progressive development phase. The basis of the measurement process is knowledge of the properties of artificial fluorophores or knowledge of the excitation and emission wavelength of autofluorophores.
- a variety of metabolically relevant parameters such as tryptophan, adenosine triphosphate (ATP), guanosine triphosphate (GTP), nicotinamide adenine dinucleotide phosphate (NADP), nicotinamide adenine dinucleotide reduced (NADH), kynurenine, flavin adenine dinucleotide (FAD) and autofluoride (FAD) ,
- the determination of this autofluorescence has the advantage that no unphysiological substances have to be added to the metabolism.
- the patent, DE 35 42 167 A1 uses the change in the autofluorescence of ascorbic acid during the oxidation process to determine the clouding of the eye lens in a non-invasive method.
- the invention is based on the object of proposing a method and a device which make it possible to describe control and regulating processes in human and animal metabolism in order to be able to draw conclusions about specific clinical pictures when these processes change.
- the method is intended to make the actual measurement process non-invasive and quickly repeatable, so as not to cause stress from the measurement process.
- Fig. 1 block diagram of the measured value acquisition
- FIG. 3 representation of the results of a simple biochemical model as a selection stage
- a light source 5 which consists of a laser or a controlled Xe flash lamp with a downstream monochrome filter or filter, generates the light to excite the autofluorescence and is guided to the measuring location via the light guide cable 1.
- the wavelengths of the excitation light are preferably 287 nm, 305 m, 326 nm and 337 nm.
- the fluorescent light emitted by the excitation at the measurement location is collected by the colimator 3 and coupled into the light guide cable 2 and fed to a spectrometer 6.
- the spectrometer can be equipped with a CCD line scan as well as a photomultiplier with an upstream acousto-optical monocliromator as a converter unit.
- the optical spectra, which were converted into electrical signals in the spectrometer 6, are now stored in a corresponding recliner structure 7.
- the fluorescence spectra stored in the computer which consist of the recorded wavelengths in the range from 2 ⁇ 7 nm to 600 nm and the associated fluorescence intensities, are prepared in a suitable table format for evaluation.
- the value pairings for metabolically relevant, biologically active substances such as ATP, GTP, tryptophan, oirotic acid, NADP, NADH, FAD etc. are selected from these tables.
- the excitation wavelengths and emission wavelengths of these substances were determined in extensive preliminary tests. Since different skin structures and skin components do not allow the use of the absolute values, further evaluation can only be carried out with relative values. So it is necessary to determine value pairs of the relevant, biologically active substances, and to link them with biophysical and biochemical models. These models contain substances that react with each other during the metabolism processes, convert into each other and / or influence each other in their concentration and reactivity.
- FIG. 3 shows the result of a simple biochemical model which is used as the first selection stage of the diagnosis and which consists of the combination of NADH, kynurenine, FAD, NADP and thromboxane.
- This illustration shows that even the use of five metabolically relevant substances is not sufficient to separate cancer from inflammatory diseases.
- the first selection level is only suitable to distinguish "sick" and "healthy” z ⁇ . Subsequently, further selection stages will be run through in order to differentiate inflammatory diseases from cancer or to differentiate among inflammatory diseases.
- FIG. 4 shows a separation between cancer diseases or treated cancer diseases and inflammatory diseases.
- an evaluation is carried out by self-learning systems that search for differences in the spectra of healthy subjects and patients without a known pairing of values (wavelength and intensity ) to use biologically active substances.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002501613A CA2501613A1 (en) | 2002-10-09 | 2003-10-02 | Method and device for the non-invasive analysis of metabolic processes |
EP03775045A EP1551283A1 (de) | 2002-10-09 | 2003-10-02 | Verfahren und vorrichtung zur nichtinvasiven untersuchung von stoffwechselprozessen |
JP2004542184A JP2006501906A (ja) | 2002-10-09 | 2003-10-02 | 代謝過程の非侵襲的分析のための方法および装置 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10246967.9 | 2002-10-09 | ||
DE2002146967 DE10246967A1 (de) | 2002-10-09 | 2002-10-09 | Verfahren und Vorrichtung zur nichtinvasiven Untersuchung von Stoffwechselprozessen |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004032734A1 true WO2004032734A1 (de) | 2004-04-22 |
Family
ID=32038351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2003/003278 WO2004032734A1 (de) | 2002-10-09 | 2003-10-02 | Verfahren und vorrichtung zur nichtinvasiven untersuchung von stoffwechelprozessen |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1551283A1 (de) |
JP (1) | JP2006501906A (de) |
CA (1) | CA2501613A1 (de) |
DE (1) | DE10246967A1 (de) |
WO (1) | WO2004032734A1 (de) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007128533A2 (de) * | 2006-05-05 | 2007-11-15 | Mevitec Gmbh | Vorrichtung und verfahren zur untersuchung und bewertung einer biologisch aktiven und/oder aktivierbaren substanz |
WO2009106524A2 (de) * | 2008-02-25 | 2009-09-03 | Labotech Labortechnik Gmbh | Verfahren und einrichtung zur komplexen stoffwechselanalyse |
CN102641117A (zh) * | 2011-02-21 | 2012-08-22 | 南台科技大学 | 一种非侵入式人体新陈代谢状态测量装置及方法 |
DE102012002086A1 (de) * | 2012-02-06 | 2013-08-08 | Carl Zeiss Meditec Ag | Verfahren zum Untersuchen von biologischem Gewebe und Vorrichtungen zum Untersuchen und Behandeln des Gewebes |
JP2014518730A (ja) * | 2011-05-31 | 2014-08-07 | ポリテクニカ ウッチカ | 血管内皮機能を評価するための方法およびシステム |
DE102020108957A1 (de) | 2020-03-31 | 2021-09-30 | Otto-Von-Guericke-Universität Magdeburg | Vorrichtung, Verfahren und Computerprogramm zur Fluoreszenzmessung |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101529228B (zh) * | 2006-05-05 | 2012-03-07 | 梅维泰克有限公司 | 用于生物活性和/或生物可激活物质的检查和评估的设备和方法 |
DE102010023486A1 (de) * | 2010-06-11 | 2011-12-15 | B. Braun Avitum Ag | Nachweisvorrichtung und -verfahren |
KR101335321B1 (ko) * | 2011-12-26 | 2013-12-02 | 김영기 | 활성산소 분석기와 이를 이용한 활성산소 분석방법 |
JP2015068709A (ja) * | 2013-09-27 | 2015-04-13 | 富士フイルム株式会社 | 光計測装置 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997005473A1 (en) * | 1995-08-01 | 1997-02-13 | Medispectra, Inc. | Optical microprobes and methods for spectral analysis of materials |
DE19612536A1 (de) * | 1996-03-29 | 1997-10-02 | Freitag Lutz Dr | Anordnung und Verfahren zur Diagnose von malignem Gewebe durch Fluoreszenzbetrachtung |
WO2001069199A2 (en) * | 2000-03-10 | 2001-09-20 | Bhaskar Banerjee | Methods of detecting cancer using cellular autofluorescence |
WO2002028273A2 (en) * | 2000-10-06 | 2002-04-11 | Yang Victor X D | Multi-spectral fluorescence imaging and spectroscopy device |
US6377841B1 (en) * | 2000-03-31 | 2002-04-23 | Vanderbilt University | Tumor demarcation using optical spectroscopy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5769081A (en) * | 1996-03-18 | 1998-06-23 | The Research Foundation Of City College Of New York | Method for detecting cancerous tissue using optical spectroscopy and fourier analysis |
-
2002
- 2002-10-09 DE DE2002146967 patent/DE10246967A1/de not_active Ceased
-
2003
- 2003-10-02 EP EP03775045A patent/EP1551283A1/de not_active Withdrawn
- 2003-10-02 WO PCT/DE2003/003278 patent/WO2004032734A1/de not_active Application Discontinuation
- 2003-10-02 JP JP2004542184A patent/JP2006501906A/ja active Pending
- 2003-10-02 CA CA002501613A patent/CA2501613A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997005473A1 (en) * | 1995-08-01 | 1997-02-13 | Medispectra, Inc. | Optical microprobes and methods for spectral analysis of materials |
DE19612536A1 (de) * | 1996-03-29 | 1997-10-02 | Freitag Lutz Dr | Anordnung und Verfahren zur Diagnose von malignem Gewebe durch Fluoreszenzbetrachtung |
WO2001069199A2 (en) * | 2000-03-10 | 2001-09-20 | Bhaskar Banerjee | Methods of detecting cancer using cellular autofluorescence |
US6377841B1 (en) * | 2000-03-31 | 2002-04-23 | Vanderbilt University | Tumor demarcation using optical spectroscopy |
WO2002028273A2 (en) * | 2000-10-06 | 2002-04-11 | Yang Victor X D | Multi-spectral fluorescence imaging and spectroscopy device |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007128533A2 (de) * | 2006-05-05 | 2007-11-15 | Mevitec Gmbh | Vorrichtung und verfahren zur untersuchung und bewertung einer biologisch aktiven und/oder aktivierbaren substanz |
WO2007128533A3 (de) * | 2006-05-05 | 2008-02-14 | Mevitec Gmbh | Vorrichtung und verfahren zur untersuchung und bewertung einer biologisch aktiven und/oder aktivierbaren substanz |
WO2009106524A2 (de) * | 2008-02-25 | 2009-09-03 | Labotech Labortechnik Gmbh | Verfahren und einrichtung zur komplexen stoffwechselanalyse |
WO2009106524A3 (de) * | 2008-02-25 | 2009-12-17 | Labotech Labortechnik Gmbh | Verfahren und einrichtung zur komplexen stoffwechselanalyse |
CN102641117A (zh) * | 2011-02-21 | 2012-08-22 | 南台科技大学 | 一种非侵入式人体新陈代谢状态测量装置及方法 |
CN102641117B (zh) * | 2011-02-21 | 2015-08-19 | 南台科技大学 | 一种非侵入式人体新陈代谢状态测量装置及方法 |
JP2014518730A (ja) * | 2011-05-31 | 2014-08-07 | ポリテクニカ ウッチカ | 血管内皮機能を評価するための方法およびシステム |
DE102012002086A1 (de) * | 2012-02-06 | 2013-08-08 | Carl Zeiss Meditec Ag | Verfahren zum Untersuchen von biologischem Gewebe und Vorrichtungen zum Untersuchen und Behandeln des Gewebes |
US9883804B2 (en) | 2012-02-06 | 2018-02-06 | Carl Zeiss Meditec Ag | Method and device for examining a biological tissue by analysing fluorescence response to illumination and for treating the tissue |
US10973411B2 (en) | 2012-02-06 | 2021-04-13 | Carl Zeiss Meditec Ag | Method and device for examining a biological tissue by analysing fluorescence response to illumination and for treating the tissue |
DE102020108957A1 (de) | 2020-03-31 | 2021-09-30 | Otto-Von-Guericke-Universität Magdeburg | Vorrichtung, Verfahren und Computerprogramm zur Fluoreszenzmessung |
DE102020108957B4 (de) | 2020-03-31 | 2021-10-07 | Otto-Von-Guericke-Universität Magdeburg | Vorrichtung, Verfahren und Computerprogramm zur Fluoreszenzmessung |
Also Published As
Publication number | Publication date |
---|---|
CA2501613A1 (en) | 2004-04-22 |
JP2006501906A (ja) | 2006-01-19 |
DE10246967A1 (de) | 2004-04-22 |
EP1551283A1 (de) | 2005-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE102008011013B4 (de) | Verfahren und Einrichtung zur komplexen Stoffwechselanalyse | |
DE3008651C2 (de) | Gerät zur Messung der Pneusis-Funktion | |
DE19840452B4 (de) | Verfahren und Vorrichtung zur nicht-invasiven Messung von Konzentrationen von Blutkomponenten | |
DE3528369A1 (de) | Spektralphotometer und spektralphotometrisches verfahren | |
AT403990B (de) | Gerät zur photodynamischen behandlung von lebewesen bzw. organen derselben | |
DE112004002988T5 (de) | Instrument zum nichtinvasiven Messen des Blutzuckerpegels | |
EP0555645A1 (de) | Einrichtung zum Erkennen von Karies an Zähnen | |
EP0215772A2 (de) | Verfahren und Vorrichtung zur Tumordiagnose mittels Sera | |
DE602004001794T2 (de) | Verfahren und Vorrichtung zur in vitro oder in vivo Messung der Konzentration einer Substanz | |
EP1974202A1 (de) | Faseroptisches fluoreszenzsensorsystem | |
WO2004032734A1 (de) | Verfahren und vorrichtung zur nichtinvasiven untersuchung von stoffwechelprozessen | |
DE3542167C2 (de) | ||
Anand et al. | Multimodal fiber‐probe spectroscopy allows detecting epileptogenic focal cortical dysplasia in children | |
DE4242083C2 (de) | Sensorvorrichtung zur reproduzierbaren, nichtinvasiven Messung der Blutglucose | |
Zahra | Technological advancements to reduce the influence of absorption and scattering on the optical imaging | |
EP1622503A1 (de) | Verfahren und vorrichtung zur bestimmung von blutkomponenten mittels der methode der ratiometrischen absoluten pulsspektroskopie | |
WO2003086193A1 (de) | Verfahren zur spektrometrischen bestimmung der sauerstoffsättigung von blut in gegenwart optischer störgrössen | |
US10895503B2 (en) | Medical device for fibred bimodal optical spectroscopy | |
DE10129652A1 (de) | Anordnung und Verfahren zur Bestimmung der zweidimensionalen Verteilung von Funduspigmenten, insbesondere des Makulapigments Xanthophyll | |
DE19854292C2 (de) | Verfahren und Anordnung zur multiparametrischen Diagnostik von biologischem Gewebe | |
DE19629342C2 (de) | Verfahren und Anordnung zur nicht-invasiven, transkutanen Bestimmung von Stoffkonzentrationen in Körpergeweben | |
CN108007910B (zh) | 一种用于皮肤组织荧光光谱和后向散射光光谱原位测量的深度敏感光纤探针 | |
DE102020108957B4 (de) | Vorrichtung, Verfahren und Computerprogramm zur Fluoreszenzmessung | |
EP2382916B1 (de) | Vorrichtung und Verfahren zur Bestimmung des Fettgehaltes des menschlichen Körpers | |
Dunaev et al. | Biomedical Photonics Methods in Solving Diagnostic Tasks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2501613 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003775045 Country of ref document: EP Ref document number: 2004542184 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003775045 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2003775045 Country of ref document: EP |